Kura Oncology Grants Stock Options To New Hires Under Inducement Plan
(RTTNews) – Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company focused on precision cancer therapies, announced that its Board’s Compensation Committee granted nonstatutory stock options for 79,200 shares to five new employees on June 2, 2025.